Christopher Bowden Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Bowden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Bowden. Christopher Bowden is a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a Chief Medical Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in MIRAGEN THERAPEUTICS, INC. ($MGEN).
Address: C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE 02139 MA
Companies in which Christopher Bowden is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Bowden: Chief Medical Officer
Holdings: 18,697 shares
Current Value: $830,521
Latest Transaction: Apr 21 2021
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viridian Therapeutics, Inc.\DE
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Christopher Bowden: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 22 2020
$MGEN Market Capitalization: $9.56M
$MGEN Previous Close: $10.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Bowden: Director
Holdings: 4,167 shares
Current Value: $27,919
Latest Transaction: May 06 2021
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Bowden
Sentiment: All, AGIO, MGEN, ZIOP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.31 | 31,250 | 134,688 | 31,250 | |
| May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Grant | A | 0.00 | 4,167 | 0 | 4,167 | 0 to 4.2 K |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 39.76 | 1,888 | 75,067 | 43,332 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 12,513 | 439,957 | 0 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 3,210 | 112,864 | 12,513 | |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 55.11 | 14,401 | 793,582 | 15,487 | 29.9 K to 15.5 K (-48.18 %) |
| Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 39.76 | 1,888 | 75,067 | 29,888 | 28 K to 29.9 K (+6.74 %) |